Mizuho Medy Co.,Ltd. (4595.T) JPX
1,677.00
-2(-0.12%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Mizuho Medy Co.,Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
187
First IPO Date
December 18, 2015
Key Executives
| Name | Title | Pay | Year Born |
| Fuminari Karakawa | Chairman of the Board & President | 0 | 1945 |
| Kazuhiro Ichimaru | GM of Intellectual Property & Manufacturing Department and Director | 0 | 1960 |
| Toshio Kamihara | GM of Sales Division & Overseas Business Department and Director | 0 | 1964 |
| Takahiro Furuno | Executive Officer & Manager of Manufacturing Department | 0 | N/A |
| Kenji Narahara | GM of Development Department & Director | 0 | 1963 |
Description
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.
